动物抗生素和抗菌药物市场－全球产业规模、份额、趋势、机会和预测，按产品、给药方式、动物类型、地区和竞争格局划分，2020-2030年预测

2024年全球动物抗生素和抗菌药物市场规模为51亿美元，预计2030年将以4.06%的复合年增长率增长至64.8亿美元。动物抗生素和抗菌药物是一种旨在抑製或清除牲畜和伴侣动物体内微生物（包括细菌、病毒、真菌和寄生虫）的药物。全球动物性蛋白质需求的不断增长是推动这些产品市场发展的主要因素，而这又需要强而有力的动物健康管理来最大限度地提高生产力。此外，动物疾病和人畜共患病感染的日益普遍，以及生产者和宠物主人对动物健康和福利意识的不断提高，也持续推动市场的扩张。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球动物抗生素和抗菌药物市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 副产物（四环素、青霉素、磺胺类、大环内酯类、头孢菌素类、林可酰胺类）
  • 依给药途径（预混剂、口服溶液、注射剂）
  • 依动物类型（食用动物、伴侣动物）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美动物抗生素和抗菌药物市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲动物抗生素和抗菌药物市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区动物抗生素和抗菌药物市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲动物抗生素和抗菌药物市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲动物抗生素和抗菌药物市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球动物抗生素和抗菌药物市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Boehringer Ingelheim International GmbH
• Zoetis Services LLC
• Merck & co. Inc
• Elanco Animal Health Incorporated
• Phibro Animal Health Corporation
• Vetoquinol SA
• Virbac SA
• HIPRA SA
• Ceva Sante Animale SA
• Kyoritsuseiyaku Corporation

第十六章：策略建议

第17章调查会社について・免责事项

The Global Animal Antibiotics and Antimicrobials Market, valued at USD 5.10 Billion in 2024, is projected to experience a CAGR of 4.06% to reach USD 6.48 Billion by 2030. Animal antibiotics and antimicrobials are pharmaceutical agents designed to inhibit the growth of or eradicate microorganisms, including bacteria, viruses, fungi, and parasites, in livestock and companion animals. The global market for these products is primarily supported by the increasing worldwide demand for animal protein, necessitating robust animal health management to maximize productivity. Furthermore, the rising prevalence of animal diseases and zoonotic infections, coupled with growing awareness regarding animal health and welfare among producers and pet owners, drives consistent market expansion.

Key Market Drivers

The escalating global demand for animal-derived protein represents a primary driver for the animal antibiotics and antimicrobials market, as efficient livestock production relies heavily on disease prevention and control. With a growing world population and shifting dietary preferences, the need to maximize yields and ensure animal health in food-producing animals becomes increasingly critical. According to the Food and Agriculture Organization (FAO) of the United Nations, in December 2024, global meat production was forecast to increase by 1.4% to 373 million tons in 2024, demonstrating the continuous pressure on the animal agriculture sector to meet consumption needs. This sustained demand necessitates the judicious use of antimicrobials to prevent widespread disease, maintain animal welfare, and optimize productivity within intensive farming systems.

Key Market Challenges

The growing concern over antimicrobial resistance (AMR) represents a significant impediment to the expansion of the Global Animal Antibiotics and Antimicrobials Market. This challenge directly necessitates the implementation of increasingly stringent regulatory frameworks and responsible usage guidelines across various regions. Governments and international bodies are imposing stricter controls on the prescription, sale, and administration of these vital drugs to mitigate the public health risks associated with AMR.

These heightened regulations limit the availability of certain antimicrobial classes and restrict their application, particularly for non-therapeutic purposes such as growth promotion. The transition of many medically important antimicrobials from over-the-counter to prescription-only status, as seen with U. S. FDA guidance implemented in June 2023, directly curtails market access for producers and veterinarians.

Key Market Trends

The growing focus on antibiotic alternatives and prudent use represents a pivotal shift in global animal health management, moving from antibiotic reliance toward integrated disease prevention and responsible usage. Driven by antimicrobial resistance concerns and regulatory pressures, the market sees increased adoption of alternatives like vaccines, probiotics, and phytogenics. These bolster immunity and reduce therapeutic antibiotic needs. According to a European Surveillance of Veterinary Antimicrobial Consumption report published in November 2023, farm antibiotic sales in 31 European countries fell by 12.7% in 2022 compared to 2021. This strategic pivot towards prudent antimicrobial stewardship, alongside improved biosecurity, directly influences the market by promoting judicious consumption and preserving drug efficacy.

Key Market Players

• Boehringer Ingelheim International GmbH
• Zoetis Services LLC
• Merck & co. Inc
• Elanco Animal Health Incorporated
• Phibro Animal Health Corporation
• Vetoquinol S.A.
• Virbac S.A.
• HIPRA S.A.
• Ceva Sante Animale S.A.
• Kyoritsuseiyaku Corporation

Report Scope:

In this report, the Global Animal Antibiotics and Antimicrobials Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Antibiotics and Antimicrobials Market, By Product:

• Tetracycline
• Penicillin
• Sulfonamide
• Macrolide
• Cephalosporin
• Lincosamide

Animal Antibiotics and Antimicrobials Market, By Mode of Delivery:

• Premixes
• Oral Solutions
• Injection

Animal Antibiotics and Antimicrobials Market, By Animal Type:

• Food Producing
• Companion

Animal Antibiotics and Antimicrobials Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Animal Antibiotics and Antimicrobials Market.

Available Customizations:

Global Animal Antibiotics and Antimicrobials Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Antibiotics and Antimicrobials Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide)
  • 5.2.2. By Mode of Delivery (Premixes, Oral Solutions, Injection)
  • 5.2.3. By Animal Type (Food Producing, Companion)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Animal Antibiotics and Antimicrobials Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Mode of Delivery
  • 6.2.3. By Animal Type
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Animal Antibiotics and Antimicrobials Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Mode of Delivery
      • 6.3.1.2.3. By Animal Type
  • 6.3.2. Canada Animal Antibiotics and Antimicrobials Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Mode of Delivery
      • 6.3.2.2.3. By Animal Type
  • 6.3.3. Mexico Animal Antibiotics and Antimicrobials Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Mode of Delivery
      • 6.3.3.2.3. By Animal Type

7. Europe Animal Antibiotics and Antimicrobials Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Mode of Delivery
  • 7.2.3. By Animal Type
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Animal Antibiotics and Antimicrobials Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Mode of Delivery
      • 7.3.1.2.3. By Animal Type
  • 7.3.2. France Animal Antibiotics and Antimicrobials Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Mode of Delivery
      • 7.3.2.2.3. By Animal Type
  • 7.3.3. United Kingdom Animal Antibiotics and Antimicrobials Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Mode of Delivery
      • 7.3.3.2.3. By Animal Type
  • 7.3.4. Italy Animal Antibiotics and Antimicrobials Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Mode of Delivery
      • 7.3.4.2.3. By Animal Type
  • 7.3.5. Spain Animal Antibiotics and Antimicrobials Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Mode of Delivery
      • 7.3.5.2.3. By Animal Type

8. Asia Pacific Animal Antibiotics and Antimicrobials Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Mode of Delivery
  • 8.2.3. By Animal Type
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Animal Antibiotics and Antimicrobials Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Mode of Delivery
      • 8.3.1.2.3. By Animal Type
  • 8.3.2. India Animal Antibiotics and Antimicrobials Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Mode of Delivery
      • 8.3.2.2.3. By Animal Type
  • 8.3.3. Japan Animal Antibiotics and Antimicrobials Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Mode of Delivery
      • 8.3.3.2.3. By Animal Type
  • 8.3.4. South Korea Animal Antibiotics and Antimicrobials Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Mode of Delivery
      • 8.3.4.2.3. By Animal Type
  • 8.3.5. Australia Animal Antibiotics and Antimicrobials Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Mode of Delivery
      • 8.3.5.2.3. By Animal Type

9. Middle East & Africa Animal Antibiotics and Antimicrobials Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Mode of Delivery
  • 9.2.3. By Animal Type
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Animal Antibiotics and Antimicrobials Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Mode of Delivery
      • 9.3.1.2.3. By Animal Type
  • 9.3.2. UAE Animal Antibiotics and Antimicrobials Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Mode of Delivery
      • 9.3.2.2.3. By Animal Type
  • 9.3.3. South Africa Animal Antibiotics and Antimicrobials Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Mode of Delivery
      • 9.3.3.2.3. By Animal Type

10. South America Animal Antibiotics and Antimicrobials Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Mode of Delivery
  • 10.2.3. By Animal Type
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Animal Antibiotics and Antimicrobials Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Mode of Delivery
      • 10.3.1.2.3. By Animal Type
  • 10.3.2. Colombia Animal Antibiotics and Antimicrobials Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Mode of Delivery
      • 10.3.2.2.3. By Animal Type
  • 10.3.3. Argentina Animal Antibiotics and Antimicrobials Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Mode of Delivery
      • 10.3.3.2.3. By Animal Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Animal Antibiotics and Antimicrobials Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boehringer Ingelheim International GmbH
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Zoetis Services LLC
• 15.3. Merck & co. Inc
• 15.4. Elanco Animal Health Incorporated
• 15.5. Phibro Animal Health Corporation
• 15.6. Vetoquinol S.A.
• 15.7. Virbac S.A.
• 15.8. HIPRA S.A.
• 15.9. Ceva Sante Animale S.A.
• 15.10. Kyoritsuseiyaku Corporation

16. Strategic Recommendations

17. About Us & Disclaimer